Medical Care
Global Night Blindness Treatment Market Research Report 2024
- Aug 28, 24
- ID: 515354
- Pages: 105
- Figures: 213
- Views: 2
Night blindness, is a disorder in which your eyes are unable to adjust to low light circumstances. Night blindness is most commonly caused by abnormalities with your rod cells, but it can also be caused by a variety of other factors. Night blindness affects people's ability to see in dimly lit areas or at night. The treatment for night blindness is entirely dependent on the underlying reason. It is caused by a variety of illnesses that cause the retina's rods to degenerate. It is also termed as nyctalopia. This condition is characterized by eye pain vomiting, cloudy vision, halos, light sensitivity, distance vision problem, and headache.
The global Night Blindness Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Night Blindness Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Night Blindness Treatment.
Report Scope
The Night Blindness Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Night Blindness Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Night Blindness Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Pfizer
GlaxoSmithKline
Johnson & Johnson Private Limited
Roche Holding AG
Abbott
Mylan
Teva Pharmaceuticals
Sanofi
Novartis
Bayer
Sun Pharmaceutical Industries
Aurobindo Pharma
Lupin pharma
Eli Lilly and Company
Sumitomo Dainippon Pharma
Leo Pharma
Bausch Health
AstraZeneca
Cipla
Segment by Type
Vitamin AD Drops
Vitamin AD Softgels
Vitamin A Capsule
Segment by Application
Clinic
Hospital
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Night Blindness Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Night Blindness Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Night Blindness Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Night Blindness Treatment.
Report Scope
The Night Blindness Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Night Blindness Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Night Blindness Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Pfizer
GlaxoSmithKline
Johnson & Johnson Private Limited
Roche Holding AG
Abbott
Mylan
Teva Pharmaceuticals
Sanofi
Novartis
Bayer
Sun Pharmaceutical Industries
Aurobindo Pharma
Lupin pharma
Eli Lilly and Company
Sumitomo Dainippon Pharma
Leo Pharma
Bausch Health
AstraZeneca
Cipla
Segment by Type
Vitamin AD Drops
Vitamin AD Softgels
Vitamin A Capsule
Segment by Application
Clinic
Hospital
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Night Blindness Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Night Blindness Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Vitamin AD Drops
1.2.3 Vitamin AD Softgels
1.2.4 Vitamin A Capsule
1.3 Market by Application
1.3.1 Global Night Blindness Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinic
1.3.3 Hospital
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Night Blindness Treatment Market Perspective (2019-2030)
2.2 Night Blindness Treatment Growth Trends by Region
2.2.1 Global Night Blindness Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Night Blindness Treatment Historic Market Size by Region (2019-2024)
2.2.3 Night Blindness Treatment Forecasted Market Size by Region (2025-2030)
2.3 Night Blindness Treatment Market Dynamics
2.3.1 Night Blindness Treatment Industry Trends
2.3.2 Night Blindness Treatment Market Drivers
2.3.3 Night Blindness Treatment Market Challenges
2.3.4 Night Blindness Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Night Blindness Treatment Players by Revenue
3.1.1 Global Top Night Blindness Treatment Players by Revenue (2019-2024)
3.1.2 Global Night Blindness Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Night Blindness Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Night Blindness Treatment Revenue
3.4 Global Night Blindness Treatment Market Concentration Ratio
3.4.1 Global Night Blindness Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Night Blindness Treatment Revenue in 2023
3.5 Night Blindness Treatment Key Players Head office and Area Served
3.6 Key Players Night Blindness Treatment Product Solution and Service
3.7 Date of Enter into Night Blindness Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Night Blindness Treatment Breakdown Data by Type
4.1 Global Night Blindness Treatment Historic Market Size by Type (2019-2024)
4.2 Global Night Blindness Treatment Forecasted Market Size by Type (2025-2030)
5 Night Blindness Treatment Breakdown Data by Application
5.1 Global Night Blindness Treatment Historic Market Size by Application (2019-2024)
5.2 Global Night Blindness Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Night Blindness Treatment Market Size (2019-2030)
6.2 North America Night Blindness Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Night Blindness Treatment Market Size by Country (2019-2024)
6.4 North America Night Blindness Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Night Blindness Treatment Market Size (2019-2030)
7.2 Europe Night Blindness Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Night Blindness Treatment Market Size by Country (2019-2024)
7.4 Europe Night Blindness Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Night Blindness Treatment Market Size (2019-2030)
8.2 Asia-Pacific Night Blindness Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Night Blindness Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Night Blindness Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Night Blindness Treatment Market Size (2019-2030)
9.2 Latin America Night Blindness Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Night Blindness Treatment Market Size by Country (2019-2024)
9.4 Latin America Night Blindness Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Night Blindness Treatment Market Size (2019-2030)
10.2 Middle East & Africa Night Blindness Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Night Blindness Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Night Blindness Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Night Blindness Treatment Introduction
11.1.4 Merck Revenue in Night Blindness Treatment Business (2019-2024)
11.1.5 Merck Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Night Blindness Treatment Introduction
11.2.4 Pfizer Revenue in Night Blindness Treatment Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Night Blindness Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Night Blindness Treatment Business (2019-2024)
11.3.5 GlaxoSmithKline Recent Development
11.4 Johnson & Johnson Private Limited
11.4.1 Johnson & Johnson Private Limited Company Detail
11.4.2 Johnson & Johnson Private Limited Business Overview
11.4.3 Johnson & Johnson Private Limited Night Blindness Treatment Introduction
11.4.4 Johnson & Johnson Private Limited Revenue in Night Blindness Treatment Business (2019-2024)
11.4.5 Johnson & Johnson Private Limited Recent Development
11.5 Roche Holding AG
11.5.1 Roche Holding AG Company Detail
11.5.2 Roche Holding AG Business Overview
11.5.3 Roche Holding AG Night Blindness Treatment Introduction
11.5.4 Roche Holding AG Revenue in Night Blindness Treatment Business (2019-2024)
11.5.5 Roche Holding AG Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott Night Blindness Treatment Introduction
11.6.4 Abbott Revenue in Night Blindness Treatment Business (2019-2024)
11.6.5 Abbott Recent Development
11.7 Mylan
11.7.1 Mylan Company Detail
11.7.2 Mylan Business Overview
11.7.3 Mylan Night Blindness Treatment Introduction
11.7.4 Mylan Revenue in Night Blindness Treatment Business (2019-2024)
11.7.5 Mylan Recent Development
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Detail
11.8.2 Teva Pharmaceuticals Business Overview
11.8.3 Teva Pharmaceuticals Night Blindness Treatment Introduction
11.8.4 Teva Pharmaceuticals Revenue in Night Blindness Treatment Business (2019-2024)
11.8.5 Teva Pharmaceuticals Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Night Blindness Treatment Introduction
11.9.4 Sanofi Revenue in Night Blindness Treatment Business (2019-2024)
11.9.5 Sanofi Recent Development
11.10 Novartis
11.10.1 Novartis Company Detail
11.10.2 Novartis Business Overview
11.10.3 Novartis Night Blindness Treatment Introduction
11.10.4 Novartis Revenue in Night Blindness Treatment Business (2019-2024)
11.10.5 Novartis Recent Development
11.11 Bayer
11.11.1 Bayer Company Detail
11.11.2 Bayer Business Overview
11.11.3 Bayer Night Blindness Treatment Introduction
11.11.4 Bayer Revenue in Night Blindness Treatment Business (2019-2024)
11.11.5 Bayer Recent Development
11.12 Sun Pharmaceutical Industries
11.12.1 Sun Pharmaceutical Industries Company Detail
11.12.2 Sun Pharmaceutical Industries Business Overview
11.12.3 Sun Pharmaceutical Industries Night Blindness Treatment Introduction
11.12.4 Sun Pharmaceutical Industries Revenue in Night Blindness Treatment Business (2019-2024)
11.12.5 Sun Pharmaceutical Industries Recent Development
11.13 Aurobindo Pharma
11.13.1 Aurobindo Pharma Company Detail
11.13.2 Aurobindo Pharma Business Overview
11.13.3 Aurobindo Pharma Night Blindness Treatment Introduction
11.13.4 Aurobindo Pharma Revenue in Night Blindness Treatment Business (2019-2024)
11.13.5 Aurobindo Pharma Recent Development
11.14 Lupin pharma
11.14.1 Lupin pharma Company Detail
11.14.2 Lupin pharma Business Overview
11.14.3 Lupin pharma Night Blindness Treatment Introduction
11.14.4 Lupin pharma Revenue in Night Blindness Treatment Business (2019-2024)
11.14.5 Lupin pharma Recent Development
11.15 Eli Lilly and Company
11.15.1 Eli Lilly and Company Company Detail
11.15.2 Eli Lilly and Company Business Overview
11.15.3 Eli Lilly and Company Night Blindness Treatment Introduction
11.15.4 Eli Lilly and Company Revenue in Night Blindness Treatment Business (2019-2024)
11.15.5 Eli Lilly and Company Recent Development
11.16 Sumitomo Dainippon Pharma
11.16.1 Sumitomo Dainippon Pharma Company Detail
11.16.2 Sumitomo Dainippon Pharma Business Overview
11.16.3 Sumitomo Dainippon Pharma Night Blindness Treatment Introduction
11.16.4 Sumitomo Dainippon Pharma Revenue in Night Blindness Treatment Business (2019-2024)
11.16.5 Sumitomo Dainippon Pharma Recent Development
11.17 Leo Pharma
11.17.1 Leo Pharma Company Detail
11.17.2 Leo Pharma Business Overview
11.17.3 Leo Pharma Night Blindness Treatment Introduction
11.17.4 Leo Pharma Revenue in Night Blindness Treatment Business (2019-2024)
11.17.5 Leo Pharma Recent Development
11.18 Bausch Health
11.18.1 Bausch Health Company Detail
11.18.2 Bausch Health Business Overview
11.18.3 Bausch Health Night Blindness Treatment Introduction
11.18.4 Bausch Health Revenue in Night Blindness Treatment Business (2019-2024)
11.18.5 Bausch Health Recent Development
11.19 AstraZeneca
11.19.1 AstraZeneca Company Detail
11.19.2 AstraZeneca Business Overview
11.19.3 AstraZeneca Night Blindness Treatment Introduction
11.19.4 AstraZeneca Revenue in Night Blindness Treatment Business (2019-2024)
11.19.5 AstraZeneca Recent Development
11.20 Cipla
11.20.1 Cipla Company Detail
11.20.2 Cipla Business Overview
11.20.3 Cipla Night Blindness Treatment Introduction
11.20.4 Cipla Revenue in Night Blindness Treatment Business (2019-2024)
11.20.5 Cipla Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Night Blindness Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Vitamin AD Drops
1.2.3 Vitamin AD Softgels
1.2.4 Vitamin A Capsule
1.3 Market by Application
1.3.1 Global Night Blindness Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinic
1.3.3 Hospital
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Night Blindness Treatment Market Perspective (2019-2030)
2.2 Night Blindness Treatment Growth Trends by Region
2.2.1 Global Night Blindness Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Night Blindness Treatment Historic Market Size by Region (2019-2024)
2.2.3 Night Blindness Treatment Forecasted Market Size by Region (2025-2030)
2.3 Night Blindness Treatment Market Dynamics
2.3.1 Night Blindness Treatment Industry Trends
2.3.2 Night Blindness Treatment Market Drivers
2.3.3 Night Blindness Treatment Market Challenges
2.3.4 Night Blindness Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Night Blindness Treatment Players by Revenue
3.1.1 Global Top Night Blindness Treatment Players by Revenue (2019-2024)
3.1.2 Global Night Blindness Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Night Blindness Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Night Blindness Treatment Revenue
3.4 Global Night Blindness Treatment Market Concentration Ratio
3.4.1 Global Night Blindness Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Night Blindness Treatment Revenue in 2023
3.5 Night Blindness Treatment Key Players Head office and Area Served
3.6 Key Players Night Blindness Treatment Product Solution and Service
3.7 Date of Enter into Night Blindness Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Night Blindness Treatment Breakdown Data by Type
4.1 Global Night Blindness Treatment Historic Market Size by Type (2019-2024)
4.2 Global Night Blindness Treatment Forecasted Market Size by Type (2025-2030)
5 Night Blindness Treatment Breakdown Data by Application
5.1 Global Night Blindness Treatment Historic Market Size by Application (2019-2024)
5.2 Global Night Blindness Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Night Blindness Treatment Market Size (2019-2030)
6.2 North America Night Blindness Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Night Blindness Treatment Market Size by Country (2019-2024)
6.4 North America Night Blindness Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Night Blindness Treatment Market Size (2019-2030)
7.2 Europe Night Blindness Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Night Blindness Treatment Market Size by Country (2019-2024)
7.4 Europe Night Blindness Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Night Blindness Treatment Market Size (2019-2030)
8.2 Asia-Pacific Night Blindness Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Night Blindness Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Night Blindness Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Night Blindness Treatment Market Size (2019-2030)
9.2 Latin America Night Blindness Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Night Blindness Treatment Market Size by Country (2019-2024)
9.4 Latin America Night Blindness Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Night Blindness Treatment Market Size (2019-2030)
10.2 Middle East & Africa Night Blindness Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Night Blindness Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Night Blindness Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Night Blindness Treatment Introduction
11.1.4 Merck Revenue in Night Blindness Treatment Business (2019-2024)
11.1.5 Merck Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Night Blindness Treatment Introduction
11.2.4 Pfizer Revenue in Night Blindness Treatment Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Night Blindness Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Night Blindness Treatment Business (2019-2024)
11.3.5 GlaxoSmithKline Recent Development
11.4 Johnson & Johnson Private Limited
11.4.1 Johnson & Johnson Private Limited Company Detail
11.4.2 Johnson & Johnson Private Limited Business Overview
11.4.3 Johnson & Johnson Private Limited Night Blindness Treatment Introduction
11.4.4 Johnson & Johnson Private Limited Revenue in Night Blindness Treatment Business (2019-2024)
11.4.5 Johnson & Johnson Private Limited Recent Development
11.5 Roche Holding AG
11.5.1 Roche Holding AG Company Detail
11.5.2 Roche Holding AG Business Overview
11.5.3 Roche Holding AG Night Blindness Treatment Introduction
11.5.4 Roche Holding AG Revenue in Night Blindness Treatment Business (2019-2024)
11.5.5 Roche Holding AG Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott Night Blindness Treatment Introduction
11.6.4 Abbott Revenue in Night Blindness Treatment Business (2019-2024)
11.6.5 Abbott Recent Development
11.7 Mylan
11.7.1 Mylan Company Detail
11.7.2 Mylan Business Overview
11.7.3 Mylan Night Blindness Treatment Introduction
11.7.4 Mylan Revenue in Night Blindness Treatment Business (2019-2024)
11.7.5 Mylan Recent Development
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Detail
11.8.2 Teva Pharmaceuticals Business Overview
11.8.3 Teva Pharmaceuticals Night Blindness Treatment Introduction
11.8.4 Teva Pharmaceuticals Revenue in Night Blindness Treatment Business (2019-2024)
11.8.5 Teva Pharmaceuticals Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Night Blindness Treatment Introduction
11.9.4 Sanofi Revenue in Night Blindness Treatment Business (2019-2024)
11.9.5 Sanofi Recent Development
11.10 Novartis
11.10.1 Novartis Company Detail
11.10.2 Novartis Business Overview
11.10.3 Novartis Night Blindness Treatment Introduction
11.10.4 Novartis Revenue in Night Blindness Treatment Business (2019-2024)
11.10.5 Novartis Recent Development
11.11 Bayer
11.11.1 Bayer Company Detail
11.11.2 Bayer Business Overview
11.11.3 Bayer Night Blindness Treatment Introduction
11.11.4 Bayer Revenue in Night Blindness Treatment Business (2019-2024)
11.11.5 Bayer Recent Development
11.12 Sun Pharmaceutical Industries
11.12.1 Sun Pharmaceutical Industries Company Detail
11.12.2 Sun Pharmaceutical Industries Business Overview
11.12.3 Sun Pharmaceutical Industries Night Blindness Treatment Introduction
11.12.4 Sun Pharmaceutical Industries Revenue in Night Blindness Treatment Business (2019-2024)
11.12.5 Sun Pharmaceutical Industries Recent Development
11.13 Aurobindo Pharma
11.13.1 Aurobindo Pharma Company Detail
11.13.2 Aurobindo Pharma Business Overview
11.13.3 Aurobindo Pharma Night Blindness Treatment Introduction
11.13.4 Aurobindo Pharma Revenue in Night Blindness Treatment Business (2019-2024)
11.13.5 Aurobindo Pharma Recent Development
11.14 Lupin pharma
11.14.1 Lupin pharma Company Detail
11.14.2 Lupin pharma Business Overview
11.14.3 Lupin pharma Night Blindness Treatment Introduction
11.14.4 Lupin pharma Revenue in Night Blindness Treatment Business (2019-2024)
11.14.5 Lupin pharma Recent Development
11.15 Eli Lilly and Company
11.15.1 Eli Lilly and Company Company Detail
11.15.2 Eli Lilly and Company Business Overview
11.15.3 Eli Lilly and Company Night Blindness Treatment Introduction
11.15.4 Eli Lilly and Company Revenue in Night Blindness Treatment Business (2019-2024)
11.15.5 Eli Lilly and Company Recent Development
11.16 Sumitomo Dainippon Pharma
11.16.1 Sumitomo Dainippon Pharma Company Detail
11.16.2 Sumitomo Dainippon Pharma Business Overview
11.16.3 Sumitomo Dainippon Pharma Night Blindness Treatment Introduction
11.16.4 Sumitomo Dainippon Pharma Revenue in Night Blindness Treatment Business (2019-2024)
11.16.5 Sumitomo Dainippon Pharma Recent Development
11.17 Leo Pharma
11.17.1 Leo Pharma Company Detail
11.17.2 Leo Pharma Business Overview
11.17.3 Leo Pharma Night Blindness Treatment Introduction
11.17.4 Leo Pharma Revenue in Night Blindness Treatment Business (2019-2024)
11.17.5 Leo Pharma Recent Development
11.18 Bausch Health
11.18.1 Bausch Health Company Detail
11.18.2 Bausch Health Business Overview
11.18.3 Bausch Health Night Blindness Treatment Introduction
11.18.4 Bausch Health Revenue in Night Blindness Treatment Business (2019-2024)
11.18.5 Bausch Health Recent Development
11.19 AstraZeneca
11.19.1 AstraZeneca Company Detail
11.19.2 AstraZeneca Business Overview
11.19.3 AstraZeneca Night Blindness Treatment Introduction
11.19.4 AstraZeneca Revenue in Night Blindness Treatment Business (2019-2024)
11.19.5 AstraZeneca Recent Development
11.20 Cipla
11.20.1 Cipla Company Detail
11.20.2 Cipla Business Overview
11.20.3 Cipla Night Blindness Treatment Introduction
11.20.4 Cipla Revenue in Night Blindness Treatment Business (2019-2024)
11.20.5 Cipla Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Night Blindness Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Vitamin AD Drops
Table 3. Key Players of Vitamin AD Softgels
Table 4. Key Players of Vitamin A Capsule
Table 5. Global Night Blindness Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Night Blindness Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Night Blindness Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Night Blindness Treatment Market Share by Region (2019-2024)
Table 9. Global Night Blindness Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Night Blindness Treatment Market Share by Region (2025-2030)
Table 11. Night Blindness Treatment Market Trends
Table 12. Night Blindness Treatment Market Drivers
Table 13. Night Blindness Treatment Market Challenges
Table 14. Night Blindness Treatment Market Restraints
Table 15. Global Night Blindness Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Night Blindness Treatment Market Share by Players (2019-2024)
Table 17. Global Top Night Blindness Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Night Blindness Treatment as of 2023)
Table 18. Ranking of Global Top Night Blindness Treatment Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Night Blindness Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Night Blindness Treatment Product Solution and Service
Table 22. Date of Enter into Night Blindness Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Night Blindness Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Night Blindness Treatment Revenue Market Share by Type (2019-2024)
Table 26. Global Night Blindness Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Night Blindness Treatment Revenue Market Share by Type (2025-2030)
Table 28. Global Night Blindness Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Night Blindness Treatment Revenue Market Share by Application (2019-2024)
Table 30. Global Night Blindness Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Night Blindness Treatment Revenue Market Share by Application (2025-2030)
Table 32. North America Night Blindness Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Night Blindness Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Night Blindness Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Night Blindness Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Night Blindness Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Night Blindness Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Night Blindness Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Night Blindness Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Night Blindness Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Night Blindness Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Night Blindness Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Night Blindness Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Night Blindness Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Night Blindness Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Night Blindness Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 47. Merck Company Detail
Table 48. Merck Business Overview
Table 49. Merck Night Blindness Treatment Product
Table 50. Merck Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 51. Merck Recent Development
Table 52. Pfizer Company Detail
Table 53. Pfizer Business Overview
Table 54. Pfizer Night Blindness Treatment Product
Table 55. Pfizer Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. GlaxoSmithKline Company Detail
Table 58. GlaxoSmithKline Business Overview
Table 59. GlaxoSmithKline Night Blindness Treatment Product
Table 60. GlaxoSmithKline Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 61. GlaxoSmithKline Recent Development
Table 62. Johnson & Johnson Private Limited Company Detail
Table 63. Johnson & Johnson Private Limited Business Overview
Table 64. Johnson & Johnson Private Limited Night Blindness Treatment Product
Table 65. Johnson & Johnson Private Limited Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 66. Johnson & Johnson Private Limited Recent Development
Table 67. Roche Holding AG Company Detail
Table 68. Roche Holding AG Business Overview
Table 69. Roche Holding AG Night Blindness Treatment Product
Table 70. Roche Holding AG Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 71. Roche Holding AG Recent Development
Table 72. Abbott Company Detail
Table 73. Abbott Business Overview
Table 74. Abbott Night Blindness Treatment Product
Table 75. Abbott Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 76. Abbott Recent Development
Table 77. Mylan Company Detail
Table 78. Mylan Business Overview
Table 79. Mylan Night Blindness Treatment Product
Table 80. Mylan Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 81. Mylan Recent Development
Table 82. Teva Pharmaceuticals Company Detail
Table 83. Teva Pharmaceuticals Business Overview
Table 84. Teva Pharmaceuticals Night Blindness Treatment Product
Table 85. Teva Pharmaceuticals Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 86. Teva Pharmaceuticals Recent Development
Table 87. Sanofi Company Detail
Table 88. Sanofi Business Overview
Table 89. Sanofi Night Blindness Treatment Product
Table 90. Sanofi Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 91. Sanofi Recent Development
Table 92. Novartis Company Detail
Table 93. Novartis Business Overview
Table 94. Novartis Night Blindness Treatment Product
Table 95. Novartis Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 96. Novartis Recent Development
Table 97. Bayer Company Detail
Table 98. Bayer Business Overview
Table 99. Bayer Night Blindness Treatment Product
Table 100. Bayer Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 101. Bayer Recent Development
Table 102. Sun Pharmaceutical Industries Company Detail
Table 103. Sun Pharmaceutical Industries Business Overview
Table 104. Sun Pharmaceutical Industries Night Blindness Treatment Product
Table 105. Sun Pharmaceutical Industries Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 106. Sun Pharmaceutical Industries Recent Development
Table 107. Aurobindo Pharma Company Detail
Table 108. Aurobindo Pharma Business Overview
Table 109. Aurobindo Pharma Night Blindness Treatment Product
Table 110. Aurobindo Pharma Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 111. Aurobindo Pharma Recent Development
Table 112. Lupin pharma Company Detail
Table 113. Lupin pharma Business Overview
Table 114. Lupin pharma Night Blindness Treatment Product
Table 115. Lupin pharma Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 116. Lupin pharma Recent Development
Table 117. Eli Lilly and Company Company Detail
Table 118. Eli Lilly and Company Business Overview
Table 119. Eli Lilly and Company Night Blindness Treatment Product
Table 120. Eli Lilly and Company Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 121. Eli Lilly and Company Recent Development
Table 122. Sumitomo Dainippon Pharma Company Detail
Table 123. Sumitomo Dainippon Pharma Business Overview
Table 124. Sumitomo Dainippon Pharma Night Blindness Treatment Product
Table 125. Sumitomo Dainippon Pharma Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 126. Sumitomo Dainippon Pharma Recent Development
Table 127. Leo Pharma Company Detail
Table 128. Leo Pharma Business Overview
Table 129. Leo Pharma Night Blindness Treatment Product
Table 130. Leo Pharma Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 131. Leo Pharma Recent Development
Table 132. Bausch Health Company Detail
Table 133. Bausch Health Business Overview
Table 134. Bausch Health Night Blindness Treatment Product
Table 135. Bausch Health Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 136. Bausch Health Recent Development
Table 137. AstraZeneca Company Detail
Table 138. AstraZeneca Business Overview
Table 139. AstraZeneca Night Blindness Treatment Product
Table 140. AstraZeneca Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 141. AstraZeneca Recent Development
Table 142. Cipla Company Detail
Table 143. Cipla Business Overview
Table 144. Cipla Night Blindness Treatment Product
Table 145. Cipla Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 146. Cipla Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Night Blindness Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Night Blindness Treatment Market Share by Type: 2023 VS 2030
Figure 3. Vitamin AD Drops Features
Figure 4. Vitamin AD Softgels Features
Figure 5. Vitamin A Capsule Features
Figure 6. Global Night Blindness Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Night Blindness Treatment Market Share by Application: 2023 VS 2030
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Night Blindness Treatment Report Years Considered
Figure 11. Global Night Blindness Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Night Blindness Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Night Blindness Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global Night Blindness Treatment Market Share by Players in 2023
Figure 15. Global Top Night Blindness Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Night Blindness Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Night Blindness Treatment Revenue in 2023
Figure 17. North America Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Night Blindness Treatment Market Share by Country (2019-2030)
Figure 19. United States Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Night Blindness Treatment Market Share by Country (2019-2030)
Figure 23. Germany Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Night Blindness Treatment Market Share by Region (2019-2030)
Figure 31. China Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Night Blindness Treatment Market Share by Country (2019-2030)
Figure 39. Mexico Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Night Blindness Treatment Market Share by Country (2019-2030)
Figure 43. Turkey Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Merck Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 46. Pfizer Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 47. GlaxoSmithKline Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 48. Johnson & Johnson Private Limited Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 49. Roche Holding AG Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 50. Abbott Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 51. Mylan Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 52. Teva Pharmaceuticals Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 53. Sanofi Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 54. Novartis Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 55. Bayer Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 56. Sun Pharmaceutical Industries Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 57. Aurobindo Pharma Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 58. Lupin pharma Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 59. Eli Lilly and Company Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 60. Sumitomo Dainippon Pharma Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 61. Leo Pharma Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 62. Bausch Health Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 63. AstraZeneca Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 64. Cipla Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Night Blindness Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Vitamin AD Drops
Table 3. Key Players of Vitamin AD Softgels
Table 4. Key Players of Vitamin A Capsule
Table 5. Global Night Blindness Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Night Blindness Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Night Blindness Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Night Blindness Treatment Market Share by Region (2019-2024)
Table 9. Global Night Blindness Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Night Blindness Treatment Market Share by Region (2025-2030)
Table 11. Night Blindness Treatment Market Trends
Table 12. Night Blindness Treatment Market Drivers
Table 13. Night Blindness Treatment Market Challenges
Table 14. Night Blindness Treatment Market Restraints
Table 15. Global Night Blindness Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Night Blindness Treatment Market Share by Players (2019-2024)
Table 17. Global Top Night Blindness Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Night Blindness Treatment as of 2023)
Table 18. Ranking of Global Top Night Blindness Treatment Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Night Blindness Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Night Blindness Treatment Product Solution and Service
Table 22. Date of Enter into Night Blindness Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Night Blindness Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Night Blindness Treatment Revenue Market Share by Type (2019-2024)
Table 26. Global Night Blindness Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Night Blindness Treatment Revenue Market Share by Type (2025-2030)
Table 28. Global Night Blindness Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Night Blindness Treatment Revenue Market Share by Application (2019-2024)
Table 30. Global Night Blindness Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Night Blindness Treatment Revenue Market Share by Application (2025-2030)
Table 32. North America Night Blindness Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Night Blindness Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Night Blindness Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Night Blindness Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Night Blindness Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Night Blindness Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Night Blindness Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Night Blindness Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Night Blindness Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Night Blindness Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Night Blindness Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Night Blindness Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Night Blindness Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Night Blindness Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Night Blindness Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 47. Merck Company Detail
Table 48. Merck Business Overview
Table 49. Merck Night Blindness Treatment Product
Table 50. Merck Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 51. Merck Recent Development
Table 52. Pfizer Company Detail
Table 53. Pfizer Business Overview
Table 54. Pfizer Night Blindness Treatment Product
Table 55. Pfizer Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. GlaxoSmithKline Company Detail
Table 58. GlaxoSmithKline Business Overview
Table 59. GlaxoSmithKline Night Blindness Treatment Product
Table 60. GlaxoSmithKline Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 61. GlaxoSmithKline Recent Development
Table 62. Johnson & Johnson Private Limited Company Detail
Table 63. Johnson & Johnson Private Limited Business Overview
Table 64. Johnson & Johnson Private Limited Night Blindness Treatment Product
Table 65. Johnson & Johnson Private Limited Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 66. Johnson & Johnson Private Limited Recent Development
Table 67. Roche Holding AG Company Detail
Table 68. Roche Holding AG Business Overview
Table 69. Roche Holding AG Night Blindness Treatment Product
Table 70. Roche Holding AG Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 71. Roche Holding AG Recent Development
Table 72. Abbott Company Detail
Table 73. Abbott Business Overview
Table 74. Abbott Night Blindness Treatment Product
Table 75. Abbott Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 76. Abbott Recent Development
Table 77. Mylan Company Detail
Table 78. Mylan Business Overview
Table 79. Mylan Night Blindness Treatment Product
Table 80. Mylan Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 81. Mylan Recent Development
Table 82. Teva Pharmaceuticals Company Detail
Table 83. Teva Pharmaceuticals Business Overview
Table 84. Teva Pharmaceuticals Night Blindness Treatment Product
Table 85. Teva Pharmaceuticals Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 86. Teva Pharmaceuticals Recent Development
Table 87. Sanofi Company Detail
Table 88. Sanofi Business Overview
Table 89. Sanofi Night Blindness Treatment Product
Table 90. Sanofi Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 91. Sanofi Recent Development
Table 92. Novartis Company Detail
Table 93. Novartis Business Overview
Table 94. Novartis Night Blindness Treatment Product
Table 95. Novartis Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 96. Novartis Recent Development
Table 97. Bayer Company Detail
Table 98. Bayer Business Overview
Table 99. Bayer Night Blindness Treatment Product
Table 100. Bayer Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 101. Bayer Recent Development
Table 102. Sun Pharmaceutical Industries Company Detail
Table 103. Sun Pharmaceutical Industries Business Overview
Table 104. Sun Pharmaceutical Industries Night Blindness Treatment Product
Table 105. Sun Pharmaceutical Industries Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 106. Sun Pharmaceutical Industries Recent Development
Table 107. Aurobindo Pharma Company Detail
Table 108. Aurobindo Pharma Business Overview
Table 109. Aurobindo Pharma Night Blindness Treatment Product
Table 110. Aurobindo Pharma Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 111. Aurobindo Pharma Recent Development
Table 112. Lupin pharma Company Detail
Table 113. Lupin pharma Business Overview
Table 114. Lupin pharma Night Blindness Treatment Product
Table 115. Lupin pharma Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 116. Lupin pharma Recent Development
Table 117. Eli Lilly and Company Company Detail
Table 118. Eli Lilly and Company Business Overview
Table 119. Eli Lilly and Company Night Blindness Treatment Product
Table 120. Eli Lilly and Company Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 121. Eli Lilly and Company Recent Development
Table 122. Sumitomo Dainippon Pharma Company Detail
Table 123. Sumitomo Dainippon Pharma Business Overview
Table 124. Sumitomo Dainippon Pharma Night Blindness Treatment Product
Table 125. Sumitomo Dainippon Pharma Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 126. Sumitomo Dainippon Pharma Recent Development
Table 127. Leo Pharma Company Detail
Table 128. Leo Pharma Business Overview
Table 129. Leo Pharma Night Blindness Treatment Product
Table 130. Leo Pharma Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 131. Leo Pharma Recent Development
Table 132. Bausch Health Company Detail
Table 133. Bausch Health Business Overview
Table 134. Bausch Health Night Blindness Treatment Product
Table 135. Bausch Health Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 136. Bausch Health Recent Development
Table 137. AstraZeneca Company Detail
Table 138. AstraZeneca Business Overview
Table 139. AstraZeneca Night Blindness Treatment Product
Table 140. AstraZeneca Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 141. AstraZeneca Recent Development
Table 142. Cipla Company Detail
Table 143. Cipla Business Overview
Table 144. Cipla Night Blindness Treatment Product
Table 145. Cipla Revenue in Night Blindness Treatment Business (2019-2024) & (US$ Million)
Table 146. Cipla Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Night Blindness Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Night Blindness Treatment Market Share by Type: 2023 VS 2030
Figure 3. Vitamin AD Drops Features
Figure 4. Vitamin AD Softgels Features
Figure 5. Vitamin A Capsule Features
Figure 6. Global Night Blindness Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Night Blindness Treatment Market Share by Application: 2023 VS 2030
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Night Blindness Treatment Report Years Considered
Figure 11. Global Night Blindness Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Night Blindness Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Night Blindness Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global Night Blindness Treatment Market Share by Players in 2023
Figure 15. Global Top Night Blindness Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Night Blindness Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Night Blindness Treatment Revenue in 2023
Figure 17. North America Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Night Blindness Treatment Market Share by Country (2019-2030)
Figure 19. United States Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Night Blindness Treatment Market Share by Country (2019-2030)
Figure 23. Germany Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Night Blindness Treatment Market Share by Region (2019-2030)
Figure 31. China Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Night Blindness Treatment Market Share by Country (2019-2030)
Figure 39. Mexico Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Night Blindness Treatment Market Share by Country (2019-2030)
Figure 43. Turkey Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Night Blindness Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Merck Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 46. Pfizer Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 47. GlaxoSmithKline Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 48. Johnson & Johnson Private Limited Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 49. Roche Holding AG Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 50. Abbott Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 51. Mylan Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 52. Teva Pharmaceuticals Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 53. Sanofi Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 54. Novartis Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 55. Bayer Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 56. Sun Pharmaceutical Industries Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 57. Aurobindo Pharma Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 58. Lupin pharma Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 59. Eli Lilly and Company Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 60. Sumitomo Dainippon Pharma Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 61. Leo Pharma Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 62. Bausch Health Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 63. AstraZeneca Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 64. Cipla Revenue Growth Rate in Night Blindness Treatment Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Camelina Seeds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 11, 24
Bentgrass Seeds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 11, 24
Barley Seeds - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 11, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232